Miriam Kidron - Mar 14, 2023 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
Chief Scientific Officer, Director
Signature
/s/ Miriam Kidron
Stock symbol
ORMP
Transactions as of
Mar 14, 2023
Transactions value $
-$201,000
Form type
4
Date filed
3/15/2023, 05:20 PM
Previous filing
Aug 1, 2022
Next filing
Apr 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Sale -$201K -100K -33.15% $2.01 202K Mar 14, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to a company owned solely by Nadav Kidron, a director and the president and chief executive officer of the Issuer, and the Reporting Person used the proceeds in connection with a personal tax payment.